The Phase 2 clinical trial results of a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. generated good data, experts have said, but they cautioned there was still no way to know how effectively it will protect people against getting the disease.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan's Lee extends hitting streak to 11; Teng, Cheng demoted to minors
07/27/2026 11:55 AM - Society
Magnitude 5 aftershocks could follow New Taipei quake: CWA
07/27/2026 11:27 AM - Society
Tropical depression could become storm but no impact on Taiwan: CWA
07/27/2026 11:00 AM - Society
Magnitude 4.8 earthquake shakes southern Taiwan
07/27/2026 10:52 AM - Society
Taiwan headline news
07/27/2026 10:38 AM